Latest

LEADS BIOLABS-B (09887.HK): Six Abstracts on Weilixin and LBL-034 Published at ESMO 2026; Three Chosen for Oral Presentations ] On 19 Oct 2026, LEADS BIOLABS-B (09887.HK) said six Weilixin and LBL-034 abstracts were published for ESMO 2026, 3 selected for preferred oral presentations.
19:49
NewTimeSpaceLEADS BIOLABS-B09887.HK
ZIJIN GOLD INTL (02259.HK): 9M Gold Output ~41 Tonnes, Up 28%; Attributable Profit US$2.01bn, Up 123% ] On 19 Oct 2026, ZIJIN GOLD INTL (02259.HK) posted 9M revenue of US$5.81bn (+70%) and attributable profit of US$2.01bn (+123%), with gold output up 28%.
19:31
NewTimeSpaceZIJIN GOLD INTL02259.HK
RIBOLIFE-B (06938.HK): Issues 14,087,085 Consideration Shares to Buy Remaining 49.71% of Ribocure ] On 19 Oct 2026, RIBOLIFE-B (06938.HK) agreed to buy the remaining 49.71% of Sweden's Ribocure via 14,087,085 new H shares (8.26%) priced at HKD 56.83 each.
19:14
NewTimeSpaceRIBOLIFE-B06938.HK
SF HOLDING (06936.HK): September Express Revenue RMB 20.835bn, Down 0.09%; Supply Chain and International Up 28.13% ] On 19 Oct 2026, SF HOLDING (06936.HK) posted Sept express revenue of RMB 20.835bn (-0.09%) and supply chain/international revenue of RMB 7.884bn (+28.13%).
19:07
NewTimeSpaceSF HOLDING06936.HK
ZHAOJIN MINING (01818.HK): Wang Ligang Resigns as ED and Board Secretary; Yang Tiejiang Appointed ED ] On 19 Oct 2026, ZHAOJIN MINING (01818.HK) said Wang Ligang resigned as ED, remuneration committee member, VP and board secretary; Yang Tiejiang became ED.
19:00
NewTimeSpaceZHAOJIN MINING01818.HK
SHENZHEN INVEST (00604.HK): Q3 Contracted Sales RMB 1.814bn; Holiday Subscriptions RMB 886mn ] On 19 Oct 2026, SHENZHEN INVEST (00604.HK) posted Q3 contracted sales of RMB 1.814bn and RMB 886mn of holiday subscriptions; 1 October footfall hit 180,000.
18:55
NewTimeSpaceSHENZHEN INVEST00604.HK
MABWELL-B (02493.HK): Phase II Data for 9MW2821 in TNBC to Be Presented at ESMO 2026; ORR 30.0% ] On 19 Oct 2026, MABWELL-B (02493.HK) said Phase II data for 9MW2821 in TNBC will be presented at ESMO 2026: ORR 30.0% and DCR 80.0% in 60 evaluable patients.
18:50
NewTimeSpaceMABWELL-B02493.HK
METIS TECHBIO-P (07666.HK): Strategic LNP Delivery Collaboration with Eli Lilly; Up to ~US$1.1bn Milestones ] On 19 Oct 2026, METIS TECHBIO-P (07666.HK) signed a strategic LNP delivery deal with Eli Lilly, with an over-US$10mn upfront and up to ~US$1.1bn in milestones.
18:40
NewTimeSpaceMETIS TECHBIO-P07666.HK
BAY AREA DEV (00737.HK): Signs Six Shenzhen-Section Works Contracts Totalling ~RMB 6.66bn; Major Transactions ] On 19 Oct 2026, BAY AREA DEV (00737.HK) signed six Shenzhen-section contracts worth ~RMB 6.66bn; TJ1/3/7 and TJ4/5 are major transactions, TJ6 discloseable.
18:35
NewTimeSpaceBAY AREA DEV00737.HK
SHANDONG XINHUA (00719.HK): Nimodipine Tablets Pass Generic Drug Consistency Evaluation ] On 19 Oct 2026, SHANDONG XINHUA (00719.HK) said nimodipine tablets passed China's generic-drug consistency evaluation, with 2025 hospital sales of ~RMB 130mn.
18:25
NewTimeSpaceSHANDONG XINHUA00719.HK
HANSOH PHARMA (03692.HK): Signs ADC Strategic Collaboration and Licence with Roche; US$400mn Upfront, Over US$15bn Milestones ] On 19 Oct 2026, HANSOH PHARMA (03692.HK) signed an ADC licensing deal with Roche, with US$400mn upfront, US$110mn a year later and over US$15bn milestones.
18:15
NewTimeSpaceHANSOH PHARMA03692.HK
HK Stock Connect Insight | YUNFENG FIN (00376.HK) proposes sale of Yunfeng Financial Markets to streamline the licensing structure; southbound holding ratio falls to 0.91% ] On October 11, YUNFENG FIN (00376.HK) published a supplemental announcement disclosing that Yunfeng Financial Markets Limited, the disposal target, recorded an after-tax loss of HKD263.4 million in 2025, and setting out the basis for determining the preliminary consideration of HKD8.05 million. The shares closed at HKD2.070 on October 16, with southbound holdings of 37.158 million shares, or 0.91% of shares in issue.
15:31
YUNFENG FIN00376.HKStock ConnectHK Stock Connect Insight
Offshore Trust Insight | GREEN TEA GROUP (06831.HK): 1H Revenue Up 16.8% YoY, Controlling Shareholders' Approximately 54.29% Stake Expected to Be Unlocked Next Month ] GREEN TEA GROUP (06831.HK) closed at HKD 4.60 on October 16, 2026, down 0.43%. The company's founders Wang Qinsong and Lu Changmei, a married couple, control more than 50% of the company through the discretionary trust "Green Tea Family Trust", with Vistra Trust (Hong Kong) Limited as trustee.
14:28
GREEN TEA GROUP06831.HKOffshore Trust
HK Stock Connect Insight | UISEE TECH (01511.HK) Down About 40% Since Stock Connect Inclusion, Still About 44% Below Offer Price of HKD 60.30 ] UISEE TECH (01511.HK) closed at HKD 33.72 on October 16, 2026, up 0.36% for the day. The company's shares have been included in the list of eligible securities under Stock Connect since September 7, 2026, with the share price down about 40.4% since inclusion.
13:32
UISEE TECH01511.HKHK Stock Connect
HK Recently Listed Stocks Insight | EXTREME VISION (06636.HK): lock-up on 1,180,000 H shares held by two cornerstone investors to expire on December 31 ] The lock-up on 1,180,000 H shares held by two cornerstone investors of EXTREME VISION (06636.HK), 9.46% of the offer shares, expires on December 31, 2026.
11:05
EXTREME VISION06636.HKHK Recently Listed Stocks Watch
AUSTRAX HLDGS (02680.HK): Expects Interim Loss of HK$4.8-5.9 Million ] On 16 October 2026, AUSTRAX HLDGS (02680.HK) expected an interim loss and comprehensive expense of HK$4.8-5.9 million, against a HK$18.3 million profit.
10:26
AUSTRAX HLDGS02680.HKProfit Warning
HK Recently Listed Stocks Insight | LAIFUAL（03952.HK）：1H Revenue Up 80.1% YoY, 5.04 Million Cornerstone Lock-up Shares to Be Unlocked at End-December ] The 5.04 million H shares held by 10 cornerstone investors of LAIFUAL (03952.HK) will see their lock-up period end on December 30, 2026, with a corresponding market value of approximately HKD 431 million based on the offer price.
09:36
LAIFUAL03952.HKHK Recently Listed Stocks
SEMIGHT (688808.SH): Board Approves Plan for H-Share Listing in HK ] On 17 October 2026, SEMIGHT (688808.SH) said its board approved an H-share issue and HKEX Main Board listing, pending shareholder and regulatory approval.
09:20
SEMIGHT688808.SHA+HIPO
JLC (001232.SZ): Plans H-Share Listing on HKEX Main Board ] On 17 October 2026, JLC (001232.SZ) said it is planning an H-share listing on the HKEX Main Board, with details undetermined and approvals still required.
09:18
JLC001232.SZA+HIPO
CHINARES PHARMA (03320.HK): Unit completes 2026 bond issue at 1.48% ] On 16 October 2026, CHINARES PHARMA (03320.HK) announced its wholly-owned subsidiary completed the RMB 900 million second tranche of its 2026 corporate bonds.
22:02
CHINARES PHARMA03320.HKBonds
Previous1..2930 313233..607     607 pages total
×
Share to WeChat

Open WeChat, use "Scan," and share to my Moments